Age-related macular degeneration, better known as AMD, is a disease of the retina caused by progressive degeneration of the macula, the central part of the retina. Today, it is the leading cause of visual impairment in people over 50. As disabling as it is, AMD never causes total blindness, as the peripheral part of the retina remains intact. The disease exists in two forms, with roughly equal prevalence: the atrophic or “advanced dry” form and the neovascular form known as “exudative” or “wet”. While the former currently has no curative treatment, the latter can be slowed down by injections regularly administered into the eye. These are called intravitreal injections. Although necessary, these can nevertheless represent a significant therapeutic burden for patients. This is why researchers are constantly working to try to develop new alternative treatments. Today, the French are announcing that they have made a major breakthrough in the field. In a new study, researchers from Inserm, NCRS and Sorbonne University at the Vision Institute explain that they have discovered that L-Dopa, a dopaminergic drug commonly prescribed for Parkinson’s disease, could slow the progression of neovascular AMD. “Epidemiological studies (…)
- Top Santé
This product recommended by a dermatologist is the best for removing traces of self-tanner.
To succeed in school, it is better to be born in January than in December, statisticians say.
Supplement May Boost Memory 24 Hours After Taking It
The infusion recommended by a dietician to stop bloating
She lost 10 kg in 7 months – in particular – by favoring this meat
Related News :